- Home
- FCO vs ATRA Comparison
FCO vs ATRA Comparison
Compare FCO & ATRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FCO
- ATRA
- Stock Information
- Founded
- FCO 1991
- ATRA 2012
- Country
- FCO United Kingdom
- ATRA United States
- Employees
- FCO N/A
- ATRA N/A
- Industry
- FCO Investment Managers
- ATRA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- FCO Finance
- ATRA Health Care
- Exchange
- FCO Nasdaq
- ATRA Nasdaq
- Market Cap
- FCO 80.3M
- ATRA 65.1M
- IPO Year
- FCO N/A
- ATRA 2014
- Fundamental
- Price
- FCO $5.98
- ATRA $6.57
- Analyst Decision
- FCO
- ATRA Buy
- Analyst Count
- FCO 0
- ATRA 6
- Target Price
- FCO N/A
- ATRA $25.70
- AVG Volume (30 Days)
- FCO 100.1K
- ATRA 306.8K
- Earning Date
- FCO 01-01-0001
- ATRA 11-12-2024
- Dividend Yield
- FCO 14.96%
- ATRA N/A
- EPS Growth
- FCO N/A
- ATRA N/A
- EPS
- FCO 0.43
- ATRA N/A
- Revenue
- FCO N/A
- ATRA $100,439,000.00
- Revenue This Year
- FCO N/A
- ATRA $1,339.87
- Revenue Next Year
- FCO N/A
- ATRA N/A
- P/E Ratio
- FCO $12.30
- ATRA N/A
- Revenue Growth
- FCO N/A
- ATRA 2111.34
- 52 Week Low
- FCO $4.73
- ATRA $6.50
- 52 Week High
- FCO $6.63
- ATRA $39.50
- Technical
- Relative Strength Index (RSI)
- FCO 54.52
- ATRA 32.06
- Support Level
- FCO $5.91
- ATRA $6.55
- Resistance Level
- FCO $5.98
- ATRA $17.83
- Average True Range (ATR)
- FCO 0.10
- ATRA 2.21
- MACD
- FCO 0.01
- ATRA -0.91
- Stochastic Oscillator
- FCO 71.05
- ATRA 0.16
About FCO abrdn Global Income Fund Inc.
abrdn Global Income Fund Inc is a closed-end, non-diversified management investment company. The Fund's principal investment objective is to provide high current income by investing predominantly in fixed-income securities. As a secondary investment objective, the Fund seeks capital appreciation, but only when consistent with its principal investment objective. It invests in Government Bonds & Corporate Bonds, and its investments are divided into three categories, Developed Markets, Investment Grade Developing Markets and Sub-Investment Grade Developing Markets.
About ATRA Atara Biotherapeutics Inc.
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).